Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

BioNTech SE ADR buy MoneyMoney

BioNTech SE ADR
Start price
€81.35
18.04.24 / 0%
Target price
€100.00
18.04.25
Performance (%)
2.34%
Price
€83.25
30.04.24
Summary
This prediction is currently active. The BUY prediction by MoneyMoney shows slight gains of 2.34%. This prediction currently runs until 18.04.25. The prediction end date can be changed by MoneyMoney at any time. This prediction was marked as speculative and is excluded from MoneyMoney's performance statistics.
Performance without dividends (%)
Name 1w
BioNTech SE ADR 7.896%
iShares Core DAX® 0.961%
iShares Nasdaq 100 2.626%
iShares Nikkei 225® 0.217%
iShares S&P 500 1.540%

According to MoneyMoney what are the pros and cons of BioNTech SE ADR for the foreseeable future?

Pros
EBIT growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
Differentiated customer and product portfolio
Valuable balance sheet
High Investments for future growth
Future proof or reliable business model
Capable Management
Innovative
Growths faster than the competition
Stable Large shareholder and/or long term investor
Revenue growth > 30% per year expected
Well known brand
Top 10 in its market
Could be worthwhile Investment >10% per year
Good culture
Strong uniques
positive Cash Flow expected
Sustainability is important
Good rating
Cons
Higher risks for its business
Significant cyclical dependencies
Low dividend yield expected
ROE lower than 10% per year
Increased challenges to pay loans and raise capital

Comments by MoneyMoney for this prediction

In the thread Biontech SE diskutieren
Prediction Buy
Perf. (%) 2.34%
Target price 100.000
Change
Ends at 18.04.25

Buy mit Kursziel 100,0

MoneyMoney 
0
Report Share
18.04.24

Stopped prediction by MoneyMoney for BioNTech SE ADR

buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€160.55
11.12.22
€120.00
11.12.23
-42.05%
12.12.23

EBIT growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
Higher risks for its business
MoneyMoney 
11.12.22 0%
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€210.00
14.11.21
€185.00
14.11.22
-25.98%
15.11.22

EBIT growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
Higher risks for its business
MoneyMoney 
14.11.21 0%
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€67.74
13.07.20
€250.00
04.11.21
254.74%
05.11.21

EBIT growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
Higher risks for its business
MoneyMoney 
13.07.20 0%